Abstract
Endocannabinoid system is considered a relevant player in the regulation of neuronal excitability, since it contributes to maintaining the balance of the synaptic ionic milieu. Perturbations to bioelectric conductances have been implicated in the pathophysiological processes leading to hyperexcitability and epileptic seizures. Cannabinoid influence on neurosignalling is exerted on classic receptor-mediated mechanisms or on further molecular targets. Among these, transient receptor potential vanilloid (TRPV) are ionic channels modulated by cannabinoids that are involved in the transduction of a plethora of stimuli and trigger fundamental downstream pathways in the post-synaptic site. In this review, we aim at providing a brief summary of the most recent data about the cross-talk between cannabinoid system and TRPV channels, drawing attention on their role on neuronal hyperexcitability. Then, we aim to unveil a plausible point of interaction between these neural signalling systems taking into consideration nitric oxide, a gaseous molecule inducing profound modifications to neural performances. From this novel perspective, we struggle to propose innovative cellular mechanisms in the regulation of hyperexcitability phenomena, with the goal of exploring plausible CB-related mechanisms underpinning epileptic seizures.
Similar content being viewed by others
Change history
11 December 2019
In the original publication of the article, the names of the authors were incorrectly swapped as Gambino Giuditta · Rizzo Valerio · Giglia Giuseppe · Ferraro Giuseppe · Sardo Pierangelo.
Abbreviations
- 2AG:
-
2-Arachidonoylglycerol
- 7NI:
-
7-Nitroindazole
- ACEA:
-
2′-Chloroethylamide
- AEA:
-
Anandamide
- CA1:
-
Cornus ammonis 1
- CA3:
-
Cornus ammonis 3
- cAMP/PKA:
-
Cyclic adenosine monophosphate/protein kinase A
- CAP:
-
Capsaicin
- CB:
-
Cannabinoid
- CB1R:
-
Cannabinoid receptor type 1
- CB2R:
-
Cannabinoid receptors type 2
- CCK:
-
Cholecystokinin
- cGMP:
-
Cyclic guanosine monophosphate
- CNG:
-
Cyclic nucleotide-gated
- CNS:
-
Central nervous system
- CPZ:
-
Capsazepine
- DGLα:
-
Diacylglycerol lipase α
- DSE:
-
Depolarization-induced suppression of excitation
- DSI:
-
Depolarization-induced suppression of inhibition
- eCB:
-
Endocannabinoids
- EPSCs:
-
Excitatory post-synaptic currents
- FAAH:
-
Fatty acid amide hydrolase enzyme
- GLU:
-
Glutamate
- LTD:
-
Long-term depression
- LTP:
-
Long-term potentiation
- MDA:
-
Maximal dentate gyrus activation
- l-NAME:
-
N-ω-nitro-l-arginine methyl ester
- NO:
-
Nitric oxide
- NOS:
-
NO synthase
- nNOS:
-
Neuronal NOS
- eNOS:
-
Endothelial NOS
- iNOS:
-
Inducible NOS
- PKG:
-
CGMP-dependent protein kinases
- sGC:
-
Soluble guanylyl cyclase
- TLE:
-
Temporal lobe epilepsy
- TRPV1:
-
Transient receptor potential vanilloid type 1
- VGCCs:
-
Voltage-gated Ca2+ channels
- WIN:
-
(R)-(+)WIN 55,212-2
References
Adermark L, Lovinger DM (2007) Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. Proc Natl Acad Sci USA 104:20564–20569
Aguiar DC, Moreira FA, Terzian AL, Fogac MV, Lisboa SF, Wotjakc CT et al (2014) Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels. Neurosci Biobehav Rev 46:418–428
Ahern GP, Klyachko VA, Jackson MB (2002) CGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci 25(10):510–517
Anwyl R (2009) Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharm 56(4):735–740
Arancio O, Kandel ER, Hawkins RD (1995) Activity-dependent long-term enhancement of transmitter release by presynaptic 30, 50-cyclic GMP in cultured hippocampal neurons. Nature 376:74–80
Armstrong C, Morgan RJ, Soltesz I (2009) Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis. Epilepsia 50:1657–1669
Ayala GF, Dichter M, Gumnit RJ, Matsumoto G, Spencer WA (1973) Genesis of epileptic interictal spikes: new knowledge of cortical feedback systems suggests a neurophysiological explanation of brief paroxysms. Brain Res 52:1–17
Azad SC, Marsicano G, Eberlein I, Putzke J, Zieglgänsberger W, Spanagel R et al (2001) Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse. Eur J Neurosci 13(3):561–568
Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431:312–316
Bahremand A, Nasrabady SE, Shafaroodi H, Ghasemi M, Dehpour AR (2009) Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice. Epilepsy Res 84(2–3):110–119
Banach M, Piskorska B, Czuczwar SJ, Borowicz KK (2011) Nitric oxide, epileptic seizures, and action of antiepileptic drugs. CNS Neurol Disord Drug Targets 10(7):808–819
Batista P, Fogaça MV, Guimarães FS (2015) The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors. Behav Brain Res 293:182–188
Benko R, Lazar Z, Undi S, Illenyi L, Antal A, Horvath ÖP et al (2005) Inhibition of nitric oxide synthesis blocks the inhibitory response to capsaicin in intestinal circular muscle preparations from different species. Life Sci 76:2773–2782
Bhaskaran MD, Smith BN (2010) Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. Exp Neurol 223(2):529–536
Blair RE, Deshpande LS, Sombati S, Falenski KW, Martin BR, DeLorenzo RJ (2006) Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 317:1072–1078
Borowicz KK, Luszczki J, Kleinrok Z, Czuczwar SJ (2000) 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against penthylenetetrazol-induced convulsions. J Neural Transm 107:1117–1126
Braakman HM, van Oostenbrugge RJ, van Kranen-Mastenbroek VH, de Krom MC (2009) Rimonabant induces partial seizures in a patient with a history of generalized epilepsy. Epilepsia 50(9):2171–2172
Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030–9033
Brenman JE, Bredt DS (1997) Synaptic signalling by nitric oxide. Curr Opin Neurobiol 7:374–378
Bromfield EB, Cavazos JE, Sirven JI, editors (2006) An introduction to epilepsy. West Hartford (CT): American Epilepsy Society, chapter 2, clinical epilepsy
Brown SP, Brenowitz SD, Regehr WG (2003) Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids. Nat Neurosci 6:1048–1057
Burette A, Zabel U, Weinberg RJ, Schmidt HH, Valtschanoff JG (2002) Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J Neurosci 22(20):8961–8970
Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano-Cabral F (2008) CB2 receptors in the brain: role in central immune function. Br J Pharmacol 153(2):240–251
Cai CY, Wu HY, Luo CX, Zhu DY, Zhang Y, Zhou QG et al (2019) Extracellular regulated protein kinaseis critical for the role of 5-HT1a receptor in modulating nNOS expression and anxiety-related behaviors. Behav Brain Res 357–358:88–97. https://doi.org/10.1016/J.BBR.2017.12.017
Carletti F, Ferraro G, Rizzo V, Cannizzaro C, Sardo P (2013) Antiepileptic effect of dimethyl sulfoxide in a rat model of temporal lobe epilepsy. Neurosci Lett 546:31–35
Carletti F, Gambino G, Rizzo V, Ferraro G, Sardo P (2015) Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat. Neuroscience 303:149–159. https://doi.org/10.1016/j.neuroscience.2015.06.047
Carletti F, Sardo P, Gambino G, Liu X, Ferraro G, Rizzo V (2016a) Hippocampal hyperexcitability is modulated by microtubule-active agent: evidence from in vivo and in vitro epilepsy models in the rat front cell. Neuroscience 10:29. https://doi.org/10.3389/fncel.2016.00029
Carletti F, Gambino G, Rizzo V, Ferraro G, Sardo P (2016b) Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy. Epilepsy Res 122:56–65
Carletti F, Gambino G, Rizzo V, Ferraro G, Sardo P (2017) Neuronal nitric oxide synthase is involved in CB/TRPV1 signalling: focus on control of hippocampal hyperexcitability. Epilepsy Res 138:18–25
Carletti F, Rizzo V, Gambino G, De Caro V, Sutera FM, Li Giannola et al (2018) Comparative study of the effects exerted by N-valproyl-l-phenylalanine and N-valproyl-l-tryptophan on CA1 hippocampal epileptiform activity in rat. Curr Pharm Des 24:1849–1858
Castillo PE, Younts TJ, Chávez AE, Hashimotodani Y (2012) Endocannabinoid signaling and synaptic function. Neuron 76(1):70–81
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824
Cavanaugh DJ, Chesler AT, Jackson AC, Sigal YM, Yamanaka H, Grant R et al (2011) Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 31:5067–5077
Chamberlain SE, Jane DE, Jones RS (2012) Pre- and post-synaptic functions of kainate receptors at glutamate and GABA synapses in the rat entorhinal cortex. Hippocampus 22(3):555–576
Chavez AE, Chiu CQ, Castillo PE (2010) TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci 13:1511–1518
Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37–76
Chiarlone A, Bellocchio L, Blazquez C, Resel E, Soria-Gomez E, Cannich A et al (2014) A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proc Natl Acad Sci 111:8257–8262
Cilio MR, Thiele E, Devinsky O (2014) The case for assessing cannabidiol in epilepsy. Epilepsia 55:787–790
Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139(4):1405–1415. https://doi.org/10.1016/j.neuroscience.2006.02.074
De Petrocellis L, Di Marzo V (2009) Role of endocannabinoids and endovanilloids in Ca2+ signalling. Cell Calcium 45(6):611–624. https://doi.org/10.1016/j.ceca.2009.03.003
De Petrocellis L, Di Marzo V (2010) Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J Neuroimmune Pharmacol 5(1):103–121. https://doi.org/10.1007/s11481-009-9177-z
De Petrocellis L, Nabissi M, Santoni G, Ligresti A (2017) Actions and regulation of ionotropic cannabinoid receptors. Adv Pharmacol 80:249–289. https://doi.org/10.1016/bs.apha.2017.04.001
de Vasconcelos AP, Gizard F, Marescaux C, Nehlig A (2000) Role of nitric oxide in pentylenetetrazol-induced seizures: age-dependent effects in the immature rat. Epilepsia 41(4):363–371
Del-Bel EA, Oliveira PR, Oliveira JA, Mishra PK, Jobe PC, Garcia-Cairasco N (1997) Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz J Med Biol Res 30:971–979
den Boon FS, Chameau P, Schaafsma-Zhao Q, van Aken W, Bari M, Oddi S et al (2012) Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci USA 109(9):3534–3539
Derbenev AV, Monroe MJ, Glatzer NR, Smith BN (2006) Vanilloid-mediated heterosynaptic facilitation of inhibitory synaptic input to neurons of the rat dorsal motor nucleus of the vagus. J Neurosci 26:9666–9672
Deshpande LS, Sombati S, Blair RE, Carter DS, Martin BR, DeLorenzo RJ (2007) Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett 411(1):11–16
Di Marzo V, De Petrocellis L (2012) Why do cannabinoid receptors have more than one endogenous ligand? Philos Trans R Soc Lond B Biol Sci 367(1607):3216–3228. https://doi.org/10.1098/rstb.2011.0382
Dong XP, Wang X, Xu H (2010) TRP channels of intracellular membranes. J Neurochem 113(2):313–328. https://doi.org/10.1111/j.1471-4159.2010.06626.x
Doyle MW, Bailey TW, Jin Y-H, Andresen MC (2002) Vanilloid receptors presynaptically modulate visceral afferent synaptic transmission in nucleus tractus solitarius. J Neurosci 22:8222–8229
Fawley J, Hofmann ME, Andresen MC (2014) Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission. J Neurosci 34(24):8324–8332. https://doi.org/10.1523/JNEUROSCI.0315-14.2014
Feil R, Kleppisch T (2008) NO/cGMP-dependent modulation of synaptic transmission. Handb Exp Pharmacol 184:529–560
Fernández-Ruiz J, Romero J, Velasco G, Tolón RM, Ramos JA, Guzmán M (2007) Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 28(1):39–45
Ferraro G, Sardo P (2004) Nitric oxide and brain hyperexcitability. Vivo 18:357–366
Ferraro G, Sardo P (2009) Cholecystokinin-8 sulfate modulates the anticonvulsant efficacy of vigabatrin in an experimental model of partial complex epilepsy in the rat. Epilepsia 50:721–730
Fioravanti B, De Felice M, Stucky CL, Medler KA, Luo MC, Gardell LR et al (2008) Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J Neurosci 28:11593–11602
Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017–1066
Fritschy JM, Kiener T, Bouilleret V, Loup F (1999) GABAergic neurons and GABAA-receptors in temporal lobe epilepsy. Neurochem Int 34:435–445
Fu M, Xie Z, Zuo H (2009) TRPV1: a potential target for antiepileptogenesis. Med Hypotheses 73(1):100–102
Galanopoulou AS (2007) Developmental patterns in the regulation of chloride homeostasis and GABAA receptor signaling by seizures. Epilepsia 48(Suppl 5):14–18
Gambino G, Allegra M, Sardo P, Attanzio A, Tesoriere L, Livrea MA et al (2018) Brain distribution and modulation of neuronal excitability by indicaxanthin from Opuntia ficus indica administered at nutritionally-relevant amounts. Front Aging Neurosci 10:1–11
Garthwaite J (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:2783–2802
Garzòn J, de la Torre-Madrid E, Rodrı´guez-Munoz M, Vicente-Sa´nchez A, Sa´nchez-Bla´zquez P (2009) Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine. Mol Pain 5:11
Gerra G, Zaimovic A, Gerra ML, Ciccocioppo R, Cippitelli A, Serpelloni G et al (2010) Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists. Recent Pat CNS Drug Discov 5(1):46–52
Gibson HE, Page RS, Van Hook MJ, Kauer JA (2008) TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 57:746–759
Gonzalez-Reyes LE, Ladas TP, Chiang C, Durand DM (2013) TRPV1 antagonist capsazepine suppresses 4-AP-induced epileptiform activity in vitro and electrographic seizures in vivo. Exp Neurol 250:321–332
Grima G, Benz B, Do KB (2001) Glial-derived arginine, the nitric oxide precursor, protects neurons from NMDA-induced excitotoxicity. Eur J Neurosci 14:1762–1770
Grueter BA, Brasnjo G, Malenka RC (2010) Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat Neurosci 13:1519–1525
Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F et al (2004) Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20:441–458. https://doi.org/10.1111/j.1460-9568.2004.03428.x
Hara H, Ayata C, Huang PL, Waeber C, Ayata G, Fujii M et al (1997) [3H]L-NG-nitrine binding after transient focal ischemia and NMDA-induced excitotoxicity in type I and type III nitric oxide synthase null mice. J Cereb Blood Flow Metab 17:515–526
Harraz MM, Snyder SH (2017) Antidepressant actions of ketamine mediated by the mechanistic target of rapamycin, nitric oxide, and Rheb. Neurotherapeutics 14:728–733. https://doi.org/10.1007/s13311-017-0540-0
Hillard CJ, Muthian S, Kearn CS (1999) Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. FEBS Lett 459:277–281
Hillard CJ, Jarrahian A (2005) Accumulation of anandamide: evidence for cellular diversity. Neuropharmacology 48:1072–1078
Ho KW, Ward NJ, Calkins DJ (2012) TRPV1: A stress response protein in the central nervous system. Am J Neurodegener Dis 1:1–14
Hofmann ME, Frazier CJ (2013) Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Exp Neurol 244:43–50
Hong S, Fan J, Kemmerer ES, Evans S, Li Y, Wiley JW (2009) Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat. Gut 58:202–210
Hong Z, Tian Y, Yuan Y, Qi M, Li Y, Du Y et al (2016) Enhanced oxidative stress is responsible for TRPV4-induced neurotoxicity. Front Cell Neurosci 10:232
Howlett AC (2005) Cannabinoid receptor signaling. Handb Exp Pharmacol 168:53–79
Hsieh C, Brown S, Derleth C, Mackie K (2002) Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem 73:493–501. https://doi.org/10.1046/j.1471-4159.1999.0730493.x
Hurtado-Zavala JI, Ramachandran B, Ahmed S, Halder R, Bolleyer C, Awasthi A et al (2017) TRPV1 regulates excitatory innervation of OLM neurons in the hippocampus. Nat Commun 8:15878. https://doi.org/10.1038/ncomms15878
Iannotti FA, Hill CL, Leo A, Alhusaini A, Soubrane C, Mazzarella E et al (2014) Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci 5(11):1131–1141
Itzhak Y, Perez-Lanza D, Liddie S (2014) The strength of aversive and appetitive associations and maladaptive behaviors. IUBMB Life 66:559–571. https://doi.org/10.1002/iub.1310
Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, Hargreaves KM (2006) Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J Biol Chem 281(43):32879–32890
Jia YF, Li YC, Tang YP, Cao J, Wang L, Yang Y et al (2015) Interference of TRPV1 function altered the susceptibility of PTZ-induced seizures. Front Cell Neurosci 9:20
Jin Y-H, Bailey TW, Li BY, Schild JH, Andresen MC (2004) Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals. J Neurosci 24:4709–4717
Jones JD, Carney ST, Vrana KE, Norford DC, Howlett AC (2008) Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells. Neuropharmacology 54(1):23–30
Katona I, Urbán GM, Wallace M, Ledent C, Jung KM, Piomelli D et al (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26:5628–5637
Kauer JA, Gibson HE (2009) Hot flash: TRPV channels in the brain. Trends Neurosci 32(4):215–224. https://doi.org/10.1016/j.tins.2008.12.006
Kim SH, Won SJ, Mao XO, Ledent C, Jin K, Greenberg DA (2006a) Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis. J Pharmacol Exp Ther 319(1):150–154
Kim SH, Won SJ, Mao XO, Jin K, Greenberg DA (2006b) Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol Pharmacol 69(3):691–696
Kiss JP (2000) Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res Bull 52:459–466
Kiss JP, Vizi ES (2001) Nitric oxide: a novel link between synaptic and non synaptic transmission. Trends Neurosci 24:211–215
Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717–727
Leite JP, Neder L, Arisi GM, Carlotti CG, Assirati JA, Moreira JE (2005) Plasticity, synaptic strength, and epilepsy: what can we learn from ultrastructural data? Epilepsia 46(5):S134–S141
Li D-P, Chen S-R, Pan H-L (2004) VR 1 receptor activation induces glutamate release and postsynaptic firing in the paraventricular nucleus. J Neurophysiol 92(3):1807–1816. https://doi.org/10.1152/jn.00171.2004
Li HB, Mao RR, Zhang JC, Yang Y, Cao J, Xu L (2008) Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol Psychiatry 64(4):286–292. https://doi.org/10.1016/j.biopsych.2008.02.020
Ligresti A, De Petrocellis L, Di Marzo V (2016) From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology. Physiol Rev 96(4):1593–1659
Lisboa SF, Magesto AC, Aguiar JC, Resstel LB, Guimaraes FS (2013) Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. Neuropharmacology 75:86–89
Liu X, Miller MJ, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JR (1998) Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 273:18709–18713
Ludányi A, Eross L, Czirják S, Vajda J, Halász P, Watanabe M et al (2008) Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci 28:2976–2990
Lumme A, Soinila S, Sadienemi M, Halonen T, Vanhatalo S (2000) Nitric oxide synthase immunoreactivity in the rat hippocampus after status epilepticus induced by perforant pathway stimulation. Brain Res 871:303–310
Lupica CR, Hu Y, Devinsky O, Hoffman AF (2017) Cannabinoids as hippocampal network administrators. Neuropharmacology 124:25–37. https://doi.org/10.1016/j.neuropharm.2017.04.003
Maa E, Figi P (2014) The case for medical marijuana in epilepsy. Epilepsia 55:783–786
Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A (2008) Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11(2):152–159. https://doi.org/10.1038/nn2042
Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89(9):3825–3829
Makara JK, Katona I, Nyíri G, Németh B, Ledent C, Watanabe M et al (2007) Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors. J Neurosci 27(38):10211–10222
Manna SS, Umathe SN (2012) Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures. Epilepsy Res 100(1–2):113–124
Marinelli S, Vaughan CW, Christie MJ, Connor M (2002) Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol 543:531–540
Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G et al (2003) Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci 23:3136–3144
Marinelli S, Pacioni S, Bisogno T, Di Marzo V, Prince DA, Huguenard JR et al (2008) The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci 28:13532–13541
Marinelli S, Pacioni S, Cannich A, Marsicano G, Bacci A (2009) Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat Neurosci 12:1488–1490
Marsch R, Foeller E, Rammes G, Bunck M, Kössl M, Holsboer F et al (2007) Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci 27(4):832–839. https://doi.org/10.1523/JNEUROSCI.3303-06.2007
Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A et al (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302(5642):84–88
Menigoz A, Boudes M (2011) The expression pattern of TRPV1 in brain. J Neurosci 31:13025–13027
Messeguer A, Planells-Cases R, Ferrer-Montiel A (2006) Physiology and pharmacology of the vanilloid receptor. Curr Neuropharm 4(1):1–15
Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R et al (2000) Distribution ofmRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 97:3655–3660
Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, Di Marzo V (2009) Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 34(3):593–606
Min R, Testa-Silva G, Heistek TS, Canto CB, Lodder JC, Bisogno T et al (2010) Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus. J Neurosci 30:2710–2715
Mohapatra DP, Nau C (2005) Regulation of Ca2+ -dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J Biol Chem 280:13424–13432
Monory K, Massa F, Egertová M, Eder M, Blaudzun H, Westenbroek R et al (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51(4):455–466
Monory K, Polack M, Remus A, Lutz B, Korte M (2015) Cannabinoid CB1 receptor calibrates excitatory synaptic balance in the mouse hippocampus. J Neurosci 35:3842. https://doi.org/10.1523/JNEUROSCI.3167-14.2015
Morgan NH, Stanford IM, Woodhall GL (2009) Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 57(4):356–368
Muller C, Morales P, Reggio PH (2019) Cannabinoid ligands targeting TRP channels. Front Mol Neurosci 11:1–15. https://doi.org/10.3389/fnmol.2018.00487
Musella A, De Chiara V, Rossi S, Prosperetti C, Bernardi G, Maccarrone M et al (2009) TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci 40(1):89–97. https://doi.org/10.1016/j.mcn.2008.09.001
Musella A, De Chiara V, Rossi S, Cavasinni F, Castelli M, Cantarella C et al (2010) Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience 167:864–871. https://doi.org/10.1016/j.neuroscience.2010.02.058
Navidhamidi M, Ghasemi M, Mehranfard N (2017) Epilepsy-associated alterations in hippocampal excitability. Rev Neurosci 28(3):307–334. https://doi.org/10.1515/revneuro-2016-0059
Nazıroğlu M (2015) TRPV1 channel: a potential drug target for treating epilepsy. Curr Neuropharm 13(2):239–247
Németh B, Ledent C, Freund TF, Hájos N (2008) CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN55,212-2. Neuropharmacology 54:51–57
Ohkuma S, Katsura M (2001) Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS. Prog Neurobiol 64:97–108
Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29(3):729–738
Okere CO, Kaba H, Higuchi T (2000) Importance of endogenous nitric oxide synthase in the rat hypothalamus and amygdala in mediating the response to capsaicin. J Comp Neurol 423:670–686
Oliveira MS, Skinner F, Arshadmansab MF, Garcia I, Mello CF, Knaus HG et al (2010) Altered expression and function of small-conductance (SK) Ca21-activated K1 channels in pilocarpine-treated epileptic rats. Brain Res 1348:187–199
Patwardhan AM, Jeske N, Price TJ, Gamper N, Akopian AN, Hargreaves KM (2006) The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc Natl Acad Sci USA 103(30):11393–11398. https://doi.org/10.1073/pnas.0603861103
Perchuk A, Bierbower SM, Canseco-Alba A, Mora Z, Tyrell L, Joshi N et al (2019) Developmental and behavioral effects in neonatal and adult mice following prenatal activation of endocannabinoid receptors by capsaicin. Acta Pharmacol Sin 40(3):418–424. https://doi.org/10.1038/s41401-018-0073-z
Peters JH, McDougall SJ, Fawley JA, Smith SM, Andresen MC (2010) Primary afferent activation of thermosensitive TRPV1 triggers asynchronous glutamate release at central neurons. Neuron 65:657–669
Prast H, Philippu A (2001) Nitric oxide as modulator of neuronal function. Prog Neurobiol 64(1):51–68
Przegalinski E, Baran L, Siwanowicz J (1996) The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci Lett 217:145–148
Puente N, Cui Y, Lassalle O, Lafourcade M, Georges F, Venance L et al (2011) Polymodal activation of the endocannabinoid system in the extended amygdala. Nat Neurosci 14:1542–1547
Quesada O, Hirsch J, Ben-Ari Y, Bernard C (1996) Redox sites of NMDA receptors can modulate epileptiform activity in hippocampal slices from kainic acid-treated rats. Neurosci Lett 212:171–174
Rizzo V, Ferraro G, Carletti F, Lonobile G, Cannizzaro C, Sardo P (2009) Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat. Neurosci Lett 462(2):135–139
Rizzo V, Carletti F, Gambino G, Schiera G, Cannizzaro C, Ferraro G et al (2014) Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy. Epi Res 108(10):1711–1718. https://doi.org/10.1016/j.eplepsyres.2014.10.001
Roberts JC, Davis JB, Benham CD (2004) [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res 995:176–183
Rubino T, Realini N, Castiglioni C, Guidali C, Viganó D, Marras E et al (2008) Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 18(6):1292–1301
Saffarzadeh F, Eslamizade MJ, Ghadiri T, Modarres Mousavi SM, Hadjighassem M et al (2015) Effects of TRPV1 on the hippocampal synaptic plasticity in the epileptic rat brain. Synapse 69(7):375–383
Sánchez-Blázquez P, Rodríguez-Muñoz M, Vicente-Sánchez A, Garzón J (2013) Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. Antioxid Redox Signal 19(15):1766–1782
Sardo P, Carletti F, D’Agostino S, Rizzo V, Ferraro G (2006) Involvement of nitric oxide-soluble guanylyl cyclase pathway in the control of maximal dentate gyrus activation in the rat. J Neural Transm 113(12):1855–1861
Sardo P, Ferraro G (2007) Modulatory effects of nitric oxide-active drugs on the anticonvulsant activity of lamotrigine in an experimental model of partial complex epilepsy in the rat. BMC Neurosci 8:47
Sardo P, D’Agostino S, Rizzo V, Carletti F, Lonobile G, Ferraro G (2009) In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs. J Neural Transm 116(7):831–839
Sardo P, Carletti F, D’Agostino S, Rizzo V, Lo Nobile G, Friscia S et al (2011) Nitric oxide-active compounds modulate the intensity of glutamate-evoked responses in the globus pallidus of the rat. Life Sci 88:1113–1120
Sensi SL, Jeng JM (2004) Rethinking the excitotoxic ionic milieu: the emerging role of Zn (2+) in ischemic neuronal injury. Curr Mol Med 4:87–111
Shen M, Thayer S (1999) Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol 55:8–13
Shoudai K, Peters JH, McDougall SJ, Fawley JA, Andresen MC (2010) Thermally active TRPV1 tonically drives central spontaneous glutamate release. J Neurosci 30:14470–14475
Soltesz I, Alger BE, Kzno M, Lee S-H, Lovinger DM, Ohno-Shosaku T et al (2015) Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy. Nature Rev Neurosci 16:264–277
Stafstrom CE, Carmant L (2015) Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harb Perspect Med 5(6):a022426. https://doi.org/10.1101/cshperspect.a022426
Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F et al (2007) Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci 27:13739–13749
Starowicz K, Cristino L, Di Marzo V (2008) TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr Pharm Des 14:42–54
Storozhuk MV, Zholos AV (2018) TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling. Curr Neuropharmacol 16(2):137–150. https://doi.org/10.2174/1570159X15666170424120802
Sugaya Y, Kano M (2018) Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid. Cell Mol Life Sci 15:2793–2811. https://doi.org/10.1007/s00018-018-2834-8
Sun FJ, Guo W, Zheng DH, Zhang CQ, Li S, Liu SY et al (2013) Increased expression of TRPV1 in the cortex and hippocampus from patients with mesial temporal lobe epilepsy. J Mol Neurosci 49(1):182–193. https://doi.org/10.1007/s12031-012-9878-2
Szallasi A, Blumberg PM (2007) Complex regulation of TRPV1 by vanilloids. In: Liedtke WB, Heller S (eds) TRP ion channel function in sensory transduction and cellular signaling cascades, 6th edn. CRC Press, Boca Raton
Tahmasebi L, Komaki A, Karamian R, Shahidi S, Sarihi A, Salehi I et al (2015) The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats. Eur J Pharmacol 757:68–73
Toda N, Herman AG (2005) Gastrointestinal function regulation by nitrergic efferent nerves. Pharmacol Rev 57:315–338
Toth A, Boczan J, Kedei N, Lizanecz E, Bagi Z, Papp Z et al (2005) Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res 135:162–168
Twitchell W, Brown S, Mackie K (1997) Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 78:43–501
Uliana DL, Hott SC, Lisboa SF, Resstel LB (2016) Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning. Neuropharmacology 103:257–269
van der Stelt M, Di Marzo V (2005) Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat 77:111–122
Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310(5746):329–332
Vicente-Sanchez A, Sanchez-Blazquez P, Rodriguez-Munoz M, Garzon J (2013) Hint1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate nmda receptor activity. Mol Brain 6:42
Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ (2001) Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428:51–57
Wallace MJ, Martin BR, DeLorenzo RJ (2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452:295–301
Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharm Exp Ther 307(1):129–137
Wang W, Cao X, Liu C, Liu L (2012) Cannabinoid WIN 55,212-2 inhibits TRPV1 in trigeminal ganglion neurons via PKA and PKC pathways. Neurol Sci 33(1):79–85
Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453–462
Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588–659
Wu Z, Chen SR, Pan HL (2005) Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calciumdependent calcineurin in sensory neurons. J Biol Chem 280:18142–18151
Xing J, Li J (2007) TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons. J Neurophysiol 97(1):503–511
Yang K, Kumamoto E, Furue H, Yoshimura M (1998) Capsaicin facilitates excitatory but not inhibitory synaptic transmission in substantia gelatinosa of the rat spinal cord. Neurosci Lett 255:135–138
Yang Y, Yang H, Wang Z, Varadaraj K, Kumari SS, Mergler S et al (2013) Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury. Cell Signal 25(2):501–511. https://doi.org/10.1016/j.cellsig.2012.10.015
Yang K (2016) Postnatal excitability development and innervation by functional transient receptor potential vanilloid 1 (TRPV1) terminals in neurons of the rat spinal sacral dorsal commissural nucleus: an electrophysiological study. Mol Neurobiol 53(9):6033–6042. https://doi.org/10.1007/s12035-015-9510-x
Yoshida T, Inoue R, Morii T, Takahashi N, Yamamoto S, Hara Y et al (2006) Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat Chem Biol 2(11):596–607
Yoshino Y, Ochi S, Yamazaki K, Nakata S, Iga JI, Ueno SI (2017) Endothelial nitric oxide synthase in rat brain is downregulated by sub-chronic antidepressant treatment. Psychopharmacology 234(11):1663–1669. https://doi.org/10.1007/s00213-017-4567-z
Zhou L, Zhu DY (2009) Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 20:223–230. https://doi.org/10.1016/J.NIOX.2009.03.001
Zhou QG, Zhu XH, Nemes AD, Zhu DY (2018) Neuronal nitric oxide synthase and affective disorders. IBRO Rep 5:116–132. https://doi.org/10.1016/j.ibror.2018.11.004
Zhu LJ, Li TY, Luo CX, Jiang N, Chang L, Lin YH et al (2014) CAPON-nNOS coupling can serve as a target for developing new anxiolytics. Nat Med 20:1050–1054. https://doi.org/10.1038/nm.3644
Zhuang SY, Bridges D, Grigorenko E, McCloud S, Boon A, Hampson RE et al (2005) Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology 48:1086–1096
Zschenderlein C, Gebhardt C, von Bohlen Und Halbach O, Kulisch C, Albrecht D (2011) Capsaicin-induced changes in LTP in the lateral amygdala are mediated by TRPV1. PLoS ONE 6:e16116
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no conflicts of interest.
Ethical approval
This is a review of the literature with no animal or human study that could require an ethical approval.
Informed consent
This is a review with no experiments performed on humans. All authors of the review agree with the content.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of the article was revised. First and surname tagging of all authors in author group were corrected.
Rights and permissions
About this article
Cite this article
Gambino, G., Rizzo, V., Giglia, G. et al. Cannabinoids, TRPV and nitric oxide: the three ring circus of neuronal excitability. Brain Struct Funct 225, 1–15 (2020). https://doi.org/10.1007/s00429-019-01992-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00429-019-01992-9